Symbol: |
JAG2
|
Description: |
jagged 2 [Source:HGNC Symbol;Acc:6189]
|
Location: |
Chr14:105607318-105635161[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:139
Gene |
Compound |
Gen_sig |
Exp_pattern |
JAG2 |
NSC 57958 |
0.039 |
Up |
JAG2 |
9-AC |
0.001 |
Up |
JAG2 |
Camptothecin ethylglycinate ester hydrochloride |
0.024 |
Up |
JAG2 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.005 |
Up |
JAG2 |
6H-Pyrido[4,3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-, (SP-4-1)-tetrachloroplatinate(2-) (2:1) |
0.039 |
Up |
JAG2 |
4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- |
0.029 |
Down |
JAG2 |
ANTINEOPLASTIC-625543 |
0.031 |
Down |
JAG2 |
9-AMINO-20-CAMPTOTHECIN |
0.045 |
Up |
JAG2 |
L-Lysine, N-[(methylamino)carbonyl]-N'-(phenylmethoxy- carbonyl)-, phenylmethyl ester |
0.022 |
Up |
JAG2 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3-methoxy- phenyl)methylene]-, hydrochloride |
0.027 |
Down |
JAG2 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride |
0.03 |
Down |
JAG2 |
3,8,13,18-Pentaazapentacosane pentahydrochloride |
0.043 |
Up |
JAG2 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.033 |
Up |
JAG2 |
1,4-BIS(DIETHYLAMINO)-5,8-DIHYDROXY ANTHRAQUINON |
0.019 |
Up |
JAG2 |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.008 |
Up |
Expression pattern: Sensitivity / Resistance
Total:10 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:38
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:36
Total:3 Current:1
[First] [Prev]  Next Last 
|